Preoperative hyperbaric oxygen

PreclinicalSmall molecule

Preoperative hyperbaric oxygen is one of 3 small molecule programs targeting Hyperbaric Oxygen Therapy. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Hyperbaric Oxygen TherapyUnknown status

Hyperbaric Oxygen TherapyPreclinical

Unknown status

Competition

Competitive Landscape

3 competitors in Hyperbaric Oxygen Therapy

#DrugCompanyPhaseTrials

Hyperbaric Oxygen

IIntermountain Health Care, Inc.

Phase 2

2 2

Hyperbaric Oxygen Therapy

PPaul G. Harch, M.D.

Phase 2

3 3

Preoperative hyperbaric oxygen

FFlorida Hospital Tampa Bay Division

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Hyperbaric Oxygen Therapy1 trial

Pancreaticoduodenectomy With or Without Preoperative Hyperbaric Oxygen Therapy

Unknown status·FFlorida Hospital Tampa Bay Division·N/A·NCT02575014·50 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Preoperative hyperbaric oxygen. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Preoperative hyperbaric oxygen compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Preoperative hyperbaric oxygen. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Florida Hospital Tampa Bay Division company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: FFlorida Hospital Tampa Bay Division

Preoperative hyperbaric oxygen

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Hyperbaric Oxygen Therapy1 trial

References

Drug Info

Quick Facts

Related News